4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-052592
Director sold 2,850 shares at $20.00 ($57,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OLUKOTUN ADEOYE Y Director | 2024-12-27 | Sale 10b5-1 | −2,850 | $20.00 | $57,000 | 36,740 | D |
| Open-market sales · 2,850 sh · avg $20.00 · $57,000 | |||||||
Loading xslF345X05/wk-form4_1735596735.xml…